NCT00728676View on ClinicalTrials.gov

Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

May 31, 2010

Conditions
Phenylketonuria
Trial Locations (1)

90033

LAC+USC Medical Center, Los Angeles

Sponsors

Collaborators (1)

BioMarin Pharmaceutical
All Listed Sponsors
collaborator

BioMarin Pharmaceutical

INDUSTRY

lead

Shoji Yano

OTHER